BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)

Clinical trial NCT07009899 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07009899
Sponsor: Medical College of Wisconsin
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2026-10-01
Primary completion: 2028-02-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.